From Glenside, Pennsylvania, USA:
I was in very bad control prior to my crisis, which led to getting the pump (which changed my life for the better). At that time, for the first time, I had high blood pressure and am now taking an ACE inhibitor. Might not the high pressure readings (150/90) at that time have been related to the high blood sugars? Is it advisable for my doctor to consider taking me off the ACE inhibitor temporarily to see whether I need it, now that my blood sugars are much improved (HbA1c=7.2)?
High blood pressure can occur even if you don't have diabetes, and it is important to keep the blood sugar under control to decrease the chance of developing more serious kidney problems. ACE inhibitor are also recommended for diabetics with normal blood pressure but small amounts of protein in their urine (microalbuminuria) to prevent or delay the onset of kidney problems. If you were overweight and lost weight with your improved control, there is a small possibility that you might be able to stop the blood pressure medication (assuming you also have no protein in your urine). It can be very dangerous to stop blood pressure medication abruptly. I would not make any changes in this medication without consulting with your doctor. If you are doing well on the medication with no side effects, it might not be worth the risk to stop it to see what happens.
Original posting 17 Jun 2000
Posted to Other Illnesses
|Return to the Top of This Page|
Last Updated: Tuesday April 06, 2010 15:09:10
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.